JP2019521154A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019521154A5 JP2019521154A5 JP2019501917A JP2019501917A JP2019521154A5 JP 2019521154 A5 JP2019521154 A5 JP 2019521154A5 JP 2019501917 A JP2019501917 A JP 2019501917A JP 2019501917 A JP2019501917 A JP 2019501917A JP 2019521154 A5 JP2019521154 A5 JP 2019521154A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- tumor
- dna molecule
- cell clone
- transformed cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022074854A JP2022097591A (ja) | 2016-07-13 | 2022-04-28 | 癌免疫療法用のｄｎａワクチンの製造方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16001550.9 | 2016-07-13 | ||
| EP16001550 | 2016-07-13 | ||
| PCT/EP2017/067590 WO2018011289A1 (en) | 2016-07-13 | 2017-07-12 | Process for the production of a dna vaccine for cancer immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022074854A Division JP2022097591A (ja) | 2016-07-13 | 2022-04-28 | 癌免疫療法用のｄｎａワクチンの製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019521154A JP2019521154A (ja) | 2019-07-25 |
| JP2019521154A5 true JP2019521154A5 (enExample) | 2020-08-20 |
| JP7098599B2 JP7098599B2 (ja) | 2022-07-11 |
Family
ID=56418345
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019501917A Active JP7098599B2 (ja) | 2016-07-13 | 2017-07-12 | 癌免疫療法用のｄｎａワクチンの製造方法 |
| JP2022074854A Pending JP2022097591A (ja) | 2016-07-13 | 2022-04-28 | 癌免疫療法用のｄｎａワクチンの製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022074854A Pending JP2022097591A (ja) | 2016-07-13 | 2022-04-28 | 癌免疫療法用のｄｎａワクチンの製造方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10821163B2 (enExample) |
| EP (1) | EP3484503A1 (enExample) |
| JP (2) | JP7098599B2 (enExample) |
| KR (3) | KR20230079514A (enExample) |
| CN (1) | CN109475614A (enExample) |
| AU (1) | AU2017295004B2 (enExample) |
| BR (1) | BR112019000657A2 (enExample) |
| CA (1) | CA3028549A1 (enExample) |
| IL (1) | IL263568A (enExample) |
| MX (1) | MX2019000415A (enExample) |
| RU (1) | RU2019100079A (enExample) |
| SG (1) | SG11201811258UA (enExample) |
| WO (1) | WO2018011289A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7712060B2 (ja) * | 2017-02-17 | 2025-07-23 | バクシム アクチェンゲゼルシャフト | 新規ｖｅｇｆｒ－２ターゲット免疫療法アプローチ |
| JP7097438B2 (ja) | 2017-07-11 | 2022-07-07 | アクティム・セラピューティクス・インコーポレイテッド | 遺伝子操作された免疫刺激性細菌菌株およびその使用 |
| JP7340591B2 (ja) | 2018-07-11 | 2023-09-07 | アクティム・セラピューティクス・インコーポレイテッド | 遺伝子操作された免疫刺激性細菌菌株およびその使用 |
| KR20210058825A (ko) * | 2018-09-05 | 2021-05-24 | 백심 아게 | 병용 요법용 신생항원 표적화 dna 백신 |
| US12024709B2 (en) | 2019-02-27 | 2024-07-02 | Actym Therapeutics, Inc. | Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment |
| KR20220128638A (ko) | 2020-01-13 | 2022-09-21 | 백심 아게 | 항생제와 조합되는 살모넬라-기반의 dna 백신 |
| US20250340919A1 (en) * | 2022-06-30 | 2025-11-06 | Shimadzu Corporation | Method for Preparing Analysis of Microorganisms, and Method for Analyzing Microorganisms |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3892295T3 (pl) * | 2011-05-24 | 2023-07-24 | BioNTech SE | Zindywidualizowane szczepionki przeciwnowotworowe |
| JP6251179B2 (ja) | 2011-12-22 | 2017-12-20 | バクシム アクチェンゲゼルシャフト | 弱毒化サルモネラ株を高収量で生産する方法 |
| WO2014005683A1 (en) * | 2012-07-05 | 2014-01-09 | Vaximm Ag | Dna vaccine for use in pancreatic cancer patients |
| SI2988762T1 (sl) * | 2013-04-25 | 2018-10-30 | Vaximm Ag | Vektorji na osnovi salmonele za imunoterapijo raka, usmerjeno v Wilmsov tumorski gen WT1 |
| JP6662787B2 (ja) * | 2013-12-18 | 2020-03-11 | バキシム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 癌免疫療法のための新規ｍｓｌｎ標的化ｄｎａワクチン |
| NZ721908A (en) * | 2013-12-20 | 2022-12-23 | Massachusetts Gen Hospital | Combination therapy with neoantigen vaccine |
-
2017
- 2017-07-12 CA CA3028549A patent/CA3028549A1/en active Pending
- 2017-07-12 WO PCT/EP2017/067590 patent/WO2018011289A1/en not_active Ceased
- 2017-07-12 BR BR112019000657-5A patent/BR112019000657A2/pt not_active Application Discontinuation
- 2017-07-12 KR KR1020237018125A patent/KR20230079514A/ko not_active Ceased
- 2017-07-12 KR KR1020267008900A patent/KR20260047288A/ko active Pending
- 2017-07-12 JP JP2019501917A patent/JP7098599B2/ja active Active
- 2017-07-12 RU RU2019100079A patent/RU2019100079A/ru not_active Application Discontinuation
- 2017-07-12 AU AU2017295004A patent/AU2017295004B2/en active Active
- 2017-07-12 MX MX2019000415A patent/MX2019000415A/es unknown
- 2017-07-12 US US16/315,606 patent/US10821163B2/en active Active
- 2017-07-12 SG SG11201811258UA patent/SG11201811258UA/en unknown
- 2017-07-12 KR KR1020197002050A patent/KR20190027834A/ko not_active Ceased
- 2017-07-12 EP EP17743277.0A patent/EP3484503A1/en active Pending
- 2017-07-12 CN CN201780043297.1A patent/CN109475614A/zh active Pending
-
2018
- 2018-12-06 IL IL263568A patent/IL263568A/en unknown
-
2020
- 2020-09-29 US US17/037,627 patent/US11590215B2/en active Active
-
2022
- 2022-04-28 JP JP2022074854A patent/JP2022097591A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019100079A (ru) | Способ получения днк-вакцины для иммунотерапии рака | |
| IL299249B1 (en) | Genetically modified immune cells that include adapted shrna-microRNA (shrnamir) | |
| CN113711239A (zh) | 利用ii类mhc模型鉴别新抗原 | |
| JP2022534282A5 (enExample) | ||
| Fredericks et al. | The species-specific acquisition and diversification of a K1-like family of killer toxins in budding yeasts of the Saccharomycotina | |
| RU2016136855A (ru) | Биомаркер-направленная многоцелевая иммунотерапия | |
| CN111868080A (zh) | 利用泛等位基因模型进行的新抗原鉴别 | |
| JP2019510465A5 (enExample) | ||
| CN104560864A (zh) | 利用CRISPR-Cas9系统构建的敲除IFN-β基因的293T细胞系 | |
| Malouli et al. | Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species | |
| CN105331635A (zh) | 一种诱导型慢病毒表达体系及其构建方法和应用 | |
| WO2020124830A1 (zh) | 基于人工串联启动子的枯草芽孢杆菌高效诱导表达系统 | |
| JP2019511218A5 (enExample) | ||
| CN108893417A (zh) | 一种用于高核酸酵母选育的高通量筛选体系及应用 | |
| CN105132350B (zh) | 一种减毒鼠伤寒沙门氏菌的构建方法及其所得菌株和应用 | |
| Kistler et al. | Structural dynamics of Fusarium genomes | |
| Alharbi et al. | Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity | |
| JP6384685B2 (ja) | 組換えタンパク質の発現増進のための遺伝子断片を含むベクター及びその用途 | |
| CN113423724B (zh) | Ebv表位高亲和力t细胞受体 | |
| CN103957695A (zh) | 编码在黄麻中赋予疾病抗性的酶的核酸分子 | |
| JP2017029159A5 (enExample) | ||
| CN104711240A (zh) | 禽呼肠孤病毒σA蛋白及其相关生物材料的应用 | |
| Chen et al. | Multiple-copy-gene integration on chromosome of Escherichia coli for beta-galactosidase production | |
| CN116376850A (zh) | B3基因型嵌合麻疹病毒减毒株和制备方法及用途 | |
| van der Heide et al. | Prolonged but finite antigen presentation promotes reversible defects of “helpless” memory CD8+ T cells |